Literature DB >> 32381601

Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease.

Michelle R Denburg1,2,3, Kristen Koepsell4, Jung-Jin Lee5, Jeffrey Gerber3,6, Kyle Bittinger5, Gregory E Tasian7,3,4.   

Abstract

BACKGROUND: The relationship between the composition and function of gut microbial communities and early-onset calcium oxalate kidney stone disease is unknown.
METHODS: We conducted a case-control study of 88 individuals aged 4-18 years, which included 44 individuals with kidney stones containing ≥50% calcium oxalate and 44 controls matched for age, sex, and race. Shotgun metagenomic sequencing and untargeted metabolomics were performed on stool samples.
RESULTS: Participants who were kidney stone formers had a significantly less diverse gut microbiome compared with controls. Among bacterial taxa with a prevalence >0.1%, 31 taxa were less abundant among individuals with nephrolithiasis. These included seven taxa that produce butyrate and three taxa that degrade oxalate. The lower abundance of these bacteria was reflected in decreased abundance of the gene encoding butyryl-coA dehydrogenase (P=0.02). The relative abundance of these bacteria was correlated with the levels of 18 fecal metabolites, and levels of these metabolites differed in individuals with kidney stones compared with controls. The oxalate-degrading bacterial taxa identified as decreased in those who were kidney stone formers were components of a larger abundance correlation network that included Eggerthella lenta and several Lactobacillus species. The microbial (α) diversity was associated with age of stone onset, first decreasing and then increasing with age. For the individuals who were stone formers, we found the lowest α diversity among individuals who first formed stones at age 9-14 years, whereas controls displayed no age-related differences in diversity.
CONCLUSIONS: Loss of gut bacteria, particularly loss of those that produce butyrate and degrade oxalate, associates with perturbations of the metabolome that may be upstream determinants of early-onset calcium oxalate kidney stone disease.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  intestine; kidney stones; metabolism; pediatric nephrology

Mesh:

Substances:

Year:  2020        PMID: 32381601      PMCID: PMC7269359          DOI: 10.1681/ASN.2019101131

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  52 in total

1.  Dynamics of antibiotic prescribing for children.

Authors:  Michael E Pichichero
Journal:  JAMA       Date:  2002-06-19       Impact factor: 56.272

2.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

3.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

4.  A modified electronegativity equalization method for fast and accurate calculation of atomic charges in large biological molecules.

Authors:  Yongzhong Ouyang; Fei Ye; Yizeng Liang
Journal:  Phys Chem Chem Phys       Date:  2009-05-26       Impact factor: 3.676

5.  Kidney stones associate with increased risk for myocardial infarction.

Authors:  Andrew D Rule; Veronique L Roger; L Joseph Melton; Eric J Bergstralh; Xujian Li; Patricia A Peyser; Amy E Krambeck; John C Lieske
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

6.  Kidney stones and cardiovascular events: a cohort study.

Authors:  R Todd Alexander; Brenda R Hemmelgarn; Natasha Wiebe; Aminu Bello; Susan Samuel; Scott W Klarenbach; Gary C Curhan; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

7.  Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis.

Authors:  Cheol Kwak; Hee Kyung Kim; Eui Chong Kim; Myung Sik Choi; Hyeon Hoe Kim
Journal:  Eur Urol       Date:  2003-10       Impact factor: 20.096

8.  Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.

Authors:  Zhirong Jiang; John R Asplin; Andrew P Evan; Vazhaikkurichi M Rajendran; Heino Velazquez; Timothy P Nottoli; Henry J Binder; Peter S Aronson
Journal:  Nat Genet       Date:  2006-03-12       Impact factor: 38.330

Review 9.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.

Authors:  Petra Louis; Harry J Flint
Journal:  FEMS Microbiol Lett       Date:  2009-02-13       Impact factor: 2.742

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more
  13 in total

1.  Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation.

Authors:  Caitlin W Elgarten; Ceylan Tanes; Jung-Jin Lee; Lara A Danziger-Isakov; Michael S Grimley; Michael Green; Marian G Michaels; Jessie L Barnum; Monica I Ardura; Jeffery J Auletta; Jesse Blumenstock; Alix E Seif; Kyle L Bittinger; Brian T Fisher
Journal:  Pediatr Blood Cancer       Date:  2021-10-28       Impact factor: 3.167

2.  Vinegar reduced renal calcium oxalate stones by regulating acetate metabolism in gut microbiota and crystal adhesion in rats.

Authors:  Yu Liu; Xi Jin; Yucheng Ma; Qun Sun; Hong Li; Kunjie Wang
Journal:  Int Urol Nephrol       Date:  2022-07-19       Impact factor: 2.266

Review 3.  Mechanisms of the intestinal and urinary microbiome in kidney stone disease.

Authors:  Aaron W Miller; Kristina L Penniston; Kate Fitzpatrick; José Agudelo; Gregory Tasian; Dirk Lange
Journal:  Nat Rev Urol       Date:  2022-09-20       Impact factor: 16.430

4.  Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Yang Chen; Junjie Ma; Yunze Dong; Ziyu Yang; Na Zhao; Qian Liu; Wei Zhai; Junhua Zheng
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

5.  Physical Activity Reduces the Effect of High Body Mass Index on Kidney Stones in Diabetes Participants From the 2007-2018 NHANES Cycles: A Cross-Sectional Study.

Authors:  Weipu Mao; Lei Zhang; Si Sun; Jianping Wu; Xiangyu Zou; Guangyuan Zhang; Ming Chen
Journal:  Front Public Health       Date:  2022-07-01

6.  Pathophysiology and Treatment of Enteric Hyperoxaluria.

Authors:  Celeste Witting; Craig B Langman; Dean Assimos; Michelle A Baum; Annamaria Kausz; Dawn Milliner; Greg Tasian; Elaine Worcester; Meaghan Allain; Melissa West; Felix Knauf; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 8.237

7.  Genetic Background but Not Intestinal Microbiota After Co-Housing Determines Hyperoxaluria-Related Nephrocalcinosis in Common Inbred Mouse Strains.

Authors:  Qiuyue Ma; Melissa Grigorescu; Adrian Schreiber; Ralph Kettritz; Maja Lindenmeyer; Hans-Joachim Anders; Stefanie Steiger
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

8.  Gut microbiota and the prevalence and incidence of renal stones.

Authors:  Han-Na Kim; Jae Heon Kim; Yoosoo Chang; Dongmin Yang; Kwan Joong Joo; Young-Sam Cho; Heung Jae Park; Hyung-Lae Kim; Seungho Ryu
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

Review 9.  New Insights from Metabolomics in Pediatric Renal Diseases.

Authors:  Simona Riccio; Maria Sole Valentino; Antonio Paride Passaro; Marica Izzo; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo; Anna Di Sessa
Journal:  Children (Basel)       Date:  2022-01-17

10.  Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition.

Authors:  Naveen Kachroo; Dirk Lange; Kristina L Penniston; Joshua Stern; Gregory Tasian; Petar Bajic; Alan J Wolfe; Mangesh Suryavanshi; Andrea Ticinesi; Tiziana Meschi; Manoj Monga; Aaron W Miller
Journal:  mBio       Date:  2021-08-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.